SANA Sana Biotechnology Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SANA

Price (delayed)

$10.44

Market cap

$2.3B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.46

Enterprise value

$2.27B

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and ...

Highlights
SANA's debt is up by 7% since the previous quarter but it is down by 3.8% year-on-year
The equity has contracted by 42% YoY and by 21% from the previous quarter
SANA's quick ratio is down by 21% from the previous quarter and by 16% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://sana.com
Peers: OMER OMGA

Key stats

What are the main financial stats of SANA
Market
Shares outstanding
220.45M
Market cap
$2.3B
Enterprise value
$2.27B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.16
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$283.26M
EBITDA
-$245.43M
Free cash flow
-$273.61M
Per share
EPS
-$1.46
Free cash flow per share
-$1.41
Book value per share
$1.46
Revenue per share
$0
TBVPS
$1.88
Balance sheet
Total assets
$565.3M
Total liabilities
$277.79M
Debt
$104.1M
Equity
$287.51M
Working capital
$149.03M
Liquidity
Debt to equity
0.36
Current ratio
3.31
Quick ratio
3.24
Net debt/EBITDA
0.14
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-42.7%
Return on equity
-78.9%
Return on invested capital
-88.7%
Return on capital employed
-56.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SANA stock price

How has the Sana Biotechnology stock price performed over time
Intraday
6.75%
1 week
19.72%
1 month
13.97%
1 year
89.82%
YTD
155.88%
QTD
4.4%

Financial performance

How have Sana Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$293.14M
Net income
-$283.26M
Gross margin
N/A
Net margin
N/A
The operating income has contracted by 8% YoY and by 3.1% from the previous quarter
The net income is down by 5% year-on-year and by 2.8% since the previous quarter

Growth

What is Sana Biotechnology's growth rate over time

Valuation

What is Sana Biotechnology stock price valuation
P/E
N/A
P/B
7.16
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 2.1% year-on-year
SANA's P/B is 198% above its last 4 quarters average of 2.4
The equity has contracted by 42% YoY and by 21% from the previous quarter

Efficiency

How efficient is Sana Biotechnology business performance
The company's return on invested capital has shrunk by 82% YoY and by 16% QoQ
The return on equity has dropped by 76% year-on-year and by 18% since the previous quarter
Sana Biotechnology's ROA has decreased by 48% YoY and by 13% from the previous quarter

Dividends

What is SANA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SANA.

Financial health

How did Sana Biotechnology financials performed over time
The company's total assets is 103% higher than its total liabilities
The company's total assets fell by 31% YoY and by 10% QoQ
The current ratio is down by 21% from the previous quarter and by 17% YoY
SANA's debt is 64% smaller than its equity
The debt to equity has surged by 64% year-on-year and by 38% since the previous quarter
The equity has contracted by 42% YoY and by 21% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.